Clinical Trials Logo

Filter by:
NCT ID: NCT01295450 Not yet recruiting - Anorexia Clinical Trials

Study to Evaluate the Efficacy and Tolerability of Apevinat BC Compared to Vitamin Complex

Start date: April 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and tolerability of Apevinat BC compared to vitamin complex, in the treatment of lack of appetite and prevention of deficiency of B and C vitamins.

NCT ID: NCT01297556 Not yet recruiting - Clinical trials for Irritable Bowel Syndrome

Patient Attributes for Optimal Treatment Outcome in Irritable Bowel Syndrome.

IBS
Start date: April 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if any specific patient characteristics lead to improved outcome of IBS treatment, when conventional treatment as well as Cognitive Behavioral Therapy is used in combination.

NCT ID: NCT01303614 Not yet recruiting - Clinical trials for Gynecological Pathology

Lidocaine-Prilocaine (EMLA) Cream as Analgesia in Hysterosalpingography Practice

HSG-2010
Start date: April 2011
Phase: Phase 4
Study type: Interventional

The purpose of this study is to demonstrate that Lidocaine-Prilocaine cream decrease pain during hysterosalpingography diagnostic practice.

NCT ID: NCT01311804 Not yet recruiting - Clinical trials for Unilateral Primary Osteoarthritis of Knee

An Efficacy and Safety Study of Periarticular Parecoxib Sodium for Pain Management in Total Knee Arthroplasty

Start date: April 2011
Phase: Phase 3
Study type: Interventional

Primary Research Objective: The primary objective of this study is to determine efficacy of periarticular parecoxib sodium in a multimodal cocktail versus intravenous parecoxib injections for pain management in total knee arthroplasty Secondary Research Objective: - To determine if perioperative use of parecoxib sodium was associated with improved clinical outcomes - To evaluate the safety, in terms of adverse events; serious adverse events and tolerability of parecoxib sodium in periarticular injections in a multimodal cocktail

NCT ID: NCT01313247 Not yet recruiting - Advanced Cancer Clinical Trials

Paracetamol for Cancer Pain

Start date: April 2011
Phase: Phase 4
Study type: Interventional

Randomised, double-blind placebo controlled cross-over trial Main goal: Optimize the medical pain treatment for patients with advanced cancer disease Study goal: Measure paracetamol's additional analgesic effect in a situation where the patient is concomitantly treated with oral opioids eqv. morphine > 100 mg/d.

NCT ID: NCT01313741 Not yet recruiting - Clinical trials for The Primary Disease Process Being Studied is Shoulder OA and the Effect of an All Polyethelene Glenoid Component on Shoulder Arthroplasty

This is a 2 Year Follow up Clinical and Radiographic Analysis of a Novel All Polyethelene Glenoid Component in Standard Total Shoulder Arthroplasty.

Start date: April 2011
Phase: Phase 4
Study type: Interventional

Two hundred patients will be analyzed both clinically (via validated outcomes measures) and radiographically (via 2 sets of standard radiographs) to determine the survival and degree of bone in growth of a novel all polyethelene glenoid component used in a standard FDA approved shoulder arthroplasty system.

NCT ID: NCT01317407 Not yet recruiting - Clinical trials for Postoperative Confusion

Automated Visual Monitoring for Improving Patient Safety (VIPSafe)

VIPSafe
Start date: April 2011
Phase: N/A
Study type: Observational

After an operation many patients are in a confused mental status at the intensive care unit. In this status they possibly fall out of their bed or pull out endotracheal tubes or central venous catheters accidentally. For this, they need permanently monitoring and control through intensive care personnel. The goal of the VIPSafe project is to develop robust techniques for automated patient monitoring, that rely on data from a small number of untethered sensors, which are nonetheless flexible enough to cope with a large variety of demands.

NCT ID: NCT01319032 Not yet recruiting - Clinical trials for Genetic Polymorphism Connected to Top-level Swimmers

Genetic Polymorphism and Israeli Top-level Swimmers' Performance and Expertise

Start date: April 2011
Phase: N/A
Study type: Observational

In a study conducted in our laboratory few years ago, we genotyped 22 genes in 2 athletic groups (endurance and sprinters) and in age and gender matched nonathletic controls. Few of these genes were found to be associated with athletic performance and area of specificity. Since then a few more genes have been found that are related to athletic performance, and we intend to study various genes related to 3 genetic cascade: genes associated with body fluid balance and homeostasis, genes associated with muscle strength, and genes associated with bioenergy. The results of this study compared with athletic level will provide deeper insight into the genetic mechanisms involved in performance.

NCT ID: NCT01319071 Not yet recruiting - Top-level Athletes Clinical Trials

Genetic Polymorphism and Israeli Top-level Athletes

Start date: April 2011
Phase: N/A
Study type: Observational

It is still unknown whether different genetic elements play a role in athletes' ability to create their area of specificity.In a study conducted in our laboratory few years ago, we genotyped 22 genes in 2 athletic groups (endurance and sprinters) and in age and gender matched nonathletic controls. Few of these genes were found to be associated with athletic performance and area of specificity. Since then a few more genes have been found that are related to athletic performance, and our aim in the current study is to expand our research to these new genes which include 3 genetic cascades: genes associated with body fluid balance and homeostasis, genes associated with muscle strength, and genes associated with bioenergy.

NCT ID: NCT01319825 Not yet recruiting - Chronic Migraine Clinical Trials

Preventive Treatment of Episodic and Chronic Migraine

Start date: April 2011
Phase: Phase 4
Study type: Interventional

This is an open label pilot study to determine whether milnacipran can reduce headache frequency in episodic and chronic migraine sufferers.